Top Markets
#1 Palladium Network Palladium Network +19.88%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.80%
#3 OpenEden OpenEden +13.40%
#4 MarsCoin MarsCoin +12.48%
#5 clBTC clBTC +12.08%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.74%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.57%
#8 Mantle Staked Ether Mantle Staked Ether +8.34%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#10 Kinesis Silver Kinesis Silver +6.47%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Rang in Aktien #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Aktienkurs
$0.2301
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$228.81K
Veränderung (1 Tag)
-17.82%
Veränderung (1 Jahr)
95,775.00%
Land
US
Handel The Greater Cannabis Company, Inc. (GCAN)

Kategorie

Healthcare
Kursverlauf für The Greater Cannabis Company, Inc. (GCAN)
Höchster Schlusskurs: $0.31 am 2026-08-01

Niedrigster Schlusskurs: $0.21 am 2018-09-01
Kursverlauf der Aktie von The Greater Cannabis Company, Inc. von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 105.21%
2025 16,126.48%
2024 -47.34%
2023 41.11%
2022 -82.95%
2021 14.35%
2020 -91.59%
2019 -74.42%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $58.34 59.83%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $50.11 76.63%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $186.82 44.08%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $62.63 5.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $111.21 54.46%
US